8-KRegulation FDOther EventsExhibits & Filings

Rocket Lab Corp 8-K Report, Regulation FD Disclosure (Mar 11, 2025)

Filed March 11, 2025For Securities:RKLB

Summary

Rocket Lab USA, Inc. (RKLB) has announced the establishment of an At-the-Market (ATM) equity offering program, allowing the company to sell up to $500 million of its common stock over time. This program, facilitated by a Sales Agreement with several prominent financial institutions including BofA Securities, Cantor Fitzgerald, Stifel, and TD Securities, provides Rocket Lab with financial flexibility to raise capital as needed. The offering is made effective through a shelf registration statement filed with the SEC, granting the company the ability to tap into this funding source opportunistically. While the company is not obligated to sell any shares, the ATM program offers a crucial mechanism for potential future funding needs, which could support ongoing operations, research and development, or strategic initiatives. Investors should note that the actual timing and volume of any stock sales will be at Rocket Lab's discretion, and any such sales could result in dilution of existing shareholders' ownership. The company has the right to terminate the agreement at any time, as do the sales agents.

Key Highlights

  • 1Rocket Lab has entered into an At-the-Market (ATM) Equity Offering Sales Agreement, allowing for the sale of up to $500 million in common stock.
  • 2The ATM program enables the company to raise capital opportunistically over time through named sales agents.
  • 3The offering is supported by a shelf registration statement filed with the SEC, which automatically became effective upon filing.
  • 4The company is not obligated to sell any shares, providing flexibility in capital raising.
  • 5The Sales Agreement includes customary representations, warranties, and conditions.
  • 6Either Rocket Lab or the sales agents can terminate the agreement with written notice.
  • 7The filing includes a press release detailing the sales agreement and prospectus supplement.

Frequently Asked Questions

An ATM offering allows a company to sell its shares to the public over time at prevailing market prices, rather than in a single block offering. Rocket Lab is implementing this to gain financial flexibility, enabling them to raise capital opportunistically for various corporate purposes such as funding operations, R&D, or strategic growth initiatives, without being obligated to sell stock at a specific time or price.

Rocket Lab can raise an aggregate offering price of up to $500,000,000 through this ATM Equity Offering Sales Agreement.

Yes, if Rocket Lab decides to sell shares through the ATM program, it will result in the issuance of new shares, which will dilute the ownership percentage of existing shareholders. The extent of dilution will depend on the number of shares sold and the total number of shares outstanding after the sales.

No, Rocket Lab is not obligated to sell any shares pursuant to the Sales Agreement. The company has the discretion to decide when, if, and how many shares to sell, offering significant flexibility.